BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.711
EU - Europa 2.242
AS - Asia 2.130
SA - Sud America 341
AF - Africa 52
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 8.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.621
SG - Singapore 679
IT - Italia 652
CN - Cina 522
GB - Regno Unito 363
IE - Irlanda 316
VN - Vietnam 246
BR - Brasile 236
HK - Hong Kong 232
DE - Germania 185
SE - Svezia 149
FI - Finlandia 117
FR - Francia 111
RU - Federazione Russa 87
IN - India 67
ID - Indonesia 63
KR - Corea 51
CA - Canada 50
TR - Turchia 49
AR - Argentina 37
UA - Ucraina 37
JP - Giappone 35
NL - Olanda 29
BE - Belgio 28
BG - Bulgaria 25
BD - Bangladesh 24
MX - Messico 24
PL - Polonia 24
LT - Lituania 23
CO - Colombia 21
ES - Italia 20
MY - Malesia 19
TW - Taiwan 19
IQ - Iraq 18
CZ - Repubblica Ceca 14
VE - Venezuela 14
IR - Iran 13
AT - Austria 12
EC - Ecuador 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AU - Australia 11
CL - Cile 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MA - Marocco 9
PK - Pakistan 9
AL - Albania 8
UZ - Uzbekistan 8
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
IL - Israele 5
MT - Malta 5
RO - Romania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JM - Giamaica 4
JO - Giordania 4
OM - Oman 4
PH - Filippine 4
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GA - Gabon 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
Totale 8.488
Salva come PNG Salva come JPEG
Città #
Ashburn 445
Singapore 435
Santa Clara 397
Dublin 314
Chandler 310
San Jose 221
Hong Kong 220
Fairfield 219
Southend 150
Dallas 147
Hefei 142
Beijing 112
Nyköping 112
Woodbridge 112
Helsinki 104
Ann Arbor 99
Seattle 95
London 92
Wilmington 89
Ho Chi Minh City 82
Houston 79
Council Bluffs 78
New York 74
Cambridge 72
Modena 71
Los Angeles 65
The Dalles 64
Hanoi 62
Dearborn 59
Seoul 50
Lauterbourg 45
Jakarta 44
Bologna 41
Milan 40
Munich 40
Jacksonville 38
Moscow 37
Fremont 34
Shanghai 34
São Paulo 30
Chicago 28
Rome 28
San Diego 28
Redwood City 27
Sofia 24
Princeton 23
Brussels 22
Orem 20
Frankfurt am Main 19
San Giuliano Milanese 19
Tokyo 19
Paris 18
Parma 18
Reggio Emilia 18
Bremen 17
Dong Ket 17
Warsaw 17
Eugene 15
Redondo Beach 15
Brooklyn 14
Falls Church 14
Mumbai 14
Portsmouth 14
Toronto 13
Buffalo 12
Columbus 12
Denver 11
Düsseldorf 11
Florence 11
Guangzhou 11
Haiphong 11
New Taipei 11
Izmir 10
Nuremberg 10
Phoenix 10
Chennai 9
Poplar 9
Salt Lake City 9
Baghdad 8
Brno 8
Caprarola 8
Cardiff 8
Da Nang 8
Genoa 8
Glasgow 8
Kent 8
Montreal 8
Stockholm 8
Tashkent 8
Istanbul 7
Johannesburg 7
Medellín 7
Melbourne 7
Mexico City 7
Norwalk 7
Santorso 7
Sassuolo 7
Shinjuku 7
Venezia 7
Amsterdam 6
Totale 5.726
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 415
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 371
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 370
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 368
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 348
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 341
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 340
A concise review of lenalidomide therapy for follicular lymphoma 335
The evolving role of microsatellite instability in colorectal cancer: A review 321
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 321
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 305
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 287
Breast Location for De Novo Extramedullary Myeloid Sarcoma 280
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 278
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 263
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 261
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 256
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 252
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 243
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 241
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 230
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 227
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 222
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 217
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 200
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 199
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 199
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 196
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 180
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 177
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 147
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 137
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 30
Totale 8.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 42 35 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20263.056 238 98 317 331 447 219 528 198 359 321 0 0
Totale 8.557